Project determined the physicochemical and bioactivity properties of opioid peptides: 1. Opioidmimetic dipeptides containing /Dmt/ and /Tic/ with extremely high d affinity (Ki = 0.02 nM) and selectivity (Kim/Kid = 150,000); tripeptides, containing L-Ala3, with /Kim/Kid = 20,000/. Tyr-Tic cognates weakly interacted with d receptors. Observations: (i) peptides are antagonists; (ii) smallest peptides to elicit highly potent opioid properties; (iii) free acid at C-terminus repulses binding from m receptor sites; (iv) L-isomer critical, since D-Tic decreased d binding and in combination with amide produced m selective peptides; and (v) none interacted with k receptors. Physiological data revealed that peptides were antagonists, reversing the antinociceptive activity of deltorphin icv or systemically suggesting passage through the blood rain barrier. Statistical analyses indicated that H-Dmt-Tic-OH fits one-site binding models, whereas H-Dmt-Tic-ol and the tripeptides fit two-site binding models. 2. Opioid infidelity:novel opioid peptide agonists with dual high affinity for d and m receptors. 3. Design and synthesis of deltorphin analogues modified at positions 2-4 with achiral Ca,a-dialkyl cyclic a-amino acids. Results: (I) D-isomer at position 2 not essential for high selectivity, high affinity; (ii) acid function not required for high affinity, but only for d selectivity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES090053-09
Application #
2574459
Study Section
Special Emphasis Panel (LQCB)
Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
1996
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Lazarus, Lawrence H; Okada, Yoshio (2012) Engineering endomorphin drugs: state of the art. Expert Opin Ther Pat 22:1-14
Marczak, Ewa D; Jinsmaa, Yunden; Myers, Page H et al. (2009) Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice. Eur J Pharmacol 616:115-21
Kang, Xuezhi; Chao, Dongman; Gu, Quanbao et al. (2009) delta-Opioid receptors protect from anoxic disruption of Na+ homeostasis via Na+ channel regulation. Cell Mol Life Sci 66:3505-16
Balboni, Gianfranco; Trapella, Claudio; Sasaki, Yusuke et al. (2009) Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore. J Med Chem 52:5556-9
Vergura, Raffaella; Balboni, Gianfranco; Spagnolo, Barbara et al. (2008) Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist. Peptides 29:93-103
Jinsmaa, Yunden; Marczak, Ewa D; Balboni, Gianfranco et al. (2008) Inhibition of the development of morphine tolerance by a potent dual mu-delta-opioid antagonist, H-Dmt-Tic-Lys-NH-CH2-Ph. Pharmacol Biochem Behav 90:651-7
Balboni, Gianfranco; Fiorini, Stella; Baldisserotto, Anna et al. (2008) Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic. J Med Chem 51:5109-17
Koda, Yasuko; Del Borgo, Mark; Wessling, Susanne T et al. (2008) Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides. Bioorg Med Chem 16:6286-96
Salvadori, Severo; Fiorini, Stella; Trapella, Claudio et al. (2008) Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502). Bioorg Med Chem 16:3032-8
Ryu, Eun Kyoung; Wu, Zhanhong; Chen, Kai et al. (2008) Synthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imaging. J Med Chem 51:1817-23

Showing the most recent 10 out of 48 publications